Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
Parkinson’s disease (PD) is a chronic and progressive disorder characterized neuropathologically by loss of dopamine neurons in the substantia nigra, intracellular proteinaceous inclusions, reduction of dopaminergic terminals in the striatum, and increased neuroinflammatory cells. The consequent red...
Main Authors: | Sudhakar R. Subramaniam, Howard J. Federoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnagi.2017.00176/full |
Similar Items
-
Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
by: Rachel Kelly, et al.
Published: (2020-01-01) -
Microglial Turnover in Ageing-Related Neurodegeneration: Therapeutic Avenue to Intervene in Disease Progression
by: Shofiul Azam, et al.
Published: (2021-01-01) -
The role of microglial autophagy in Parkinson’s disease
by: Rui Zhu, et al.
Published: (2022-11-01) -
Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
by: Francesca Siani, et al.
Published: (2017-05-01) -
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
by: Alexander Gerhard, et al.
Published: (2006-02-01)